MCAM and prostate carcinoma: In the past several decades, we have focused our research activities on investigating the possible role played by METCAM/MUC18 in impacting the malignant tendency of several carcinomas, such as breast carcinoma, melanoma, nasopharyngeal carcinoma and prostate cancer [9].